Search

Author/Creator Jeanfreau, Robert

1. 160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age. (31st December 2020)

Authors:
Chang, Leejah; Anderson, Evan J; Jeanfreau, Robert; He, Ying; Hicks, Bryony; Shrestha, Anju; Pandey, Aseem; Khoury, Rawia; De Bruijn, Iris; Landolfi, Victoria
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S209
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study. Issue 6 (2nd June 2020)

Authors:
Áñez, Germán; Hedrick, James; Simon, Michael W.; Christensen, Shane; Jeanfreau, Robert; Yau, Eddy; Pan, Judy; Jordanov, Emilia; Dhingra, Mandeep S.
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 16:Issue 6(2020)
Page Start:
1292
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study1. Issue 6 (14th October 2012)

Authors:
Sheldon, Eric A.; Jeanfreau, Robert; Sliman, Joseph A.; Charenkavanich, Supoat; Rousculp, Matthew D.; Dubovsky, Filip; Mallory, Raburn M.
Journal:
Influenza and other respiratory viruses
Issue:
Volume 7:Issue 6(2013:Nov.)
Page Start:
1142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial. Issue 4 (15th January 2015)

Authors:
Langley, Joanne M.; Frenette, Louise; Jeanfreau, Robert; Halperin, Scott A.; Kyle, Michael; Chu, Laurence; McNeil, Shelly; Dramé, Mamadou; Moris, Philippe; Fries, Louis; Vaughn, David W.
Journal:
Vaccine
Issue:
Volume 33:Issue 4(2015)
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial. Issue 3 (March 2019)

Authors:
Robertson, Corwin A.; Mercer, Monica; Selmani, Alexandre; Klein, Nicola P.; Jeanfreau, Robert; Greenberg, David P.
Journal:
Pediatric infectious disease journal
Issue:
Volume 38:Issue 3(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. Issue 11 (12th March 2021)

Authors:
Chang, Lee-Jah; Anderson, Evan J.; Jeanfreau, Robert; He, Ying; Hicks, Bryony; Shrestha, Anju; Pandey, Aseem; Landolfi, Victoria; DeBruijn, Iris
Journal:
Vaccine
Issue:
Volume 39:Issue 11(2021)
Page Start:
1572
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. Issue 2 (February 2021)

Authors:
de Bruyn, Guy; Gordon, David L; Steiner, Theodore; Tambyah, Paul; Cosgrove, Catherine; Martens, Mark; Bassily, Ehab; Chan, Eng-Soon; Patel, Dhaval; Chen, Josh; Torre-Cisneros, Julian; Fernando De Magalhães Francesconi, Carlos; Gesser, Richard; Jeanfreau, Robert; Launay, Odile; Laot, Thelma; Morfi...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 2(2021)
Page Start:
252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗